Cerevel Therapeutics to be Acquired by AbbVie for $8.7 Billion
By Ben Glickman Pharmaceutical giant AbbVie has announced its plans to acquire neuroscience-drug maker Cerevel Therapeutics for approximately $8.7 billion. This acquisition comes at a premium…
Cerevel Therapeutics to be Acquired by AbbVie for $8.7 Billion
By Ben Glickman Pharmaceutical giant AbbVie has announced its plans to acquire neuroscience-drug maker Cerevel Therapeutics for approximately $8.7 billion. This acquisition comes at a premium…
C3.ai Inc., a leading provider of enterprise artificial-intelligence software, revealed its financial results for the second quarter. Although the company fell slightly short on revenue…
Concerns about the 2024 GOP Presidential Nomination
Silicon Valley billionaire Reid Hoffman has shown a deep concern regarding the front-runner for the 2024 GOP presidential nomination, former President Donald Trump. During an interview with At…